查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2105703

全球同種異體移植市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Bone Allografts Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 206 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球骨移植市場預計將從2025年的25.2億美元成長至2034年的40.7億美元，預計在2026年至2034年間以5.48%的複合年成長率成長。該市場正經歷穩定成長，這主要得益於全球範圍內整形外科手術、脊椎手術和重組治療的持續增加。骨移植無需從患者身上取得額外骨骼，即可有效修復骨骼缺損、促進骨骼再生並改善手術效果。肌肉骨骼疾病的日益普遍、運動傷害的增加以及人口老化等因素，進一步推動了骨頭移植術技術在醫療保健系統中的應用。

醫療專業人員擴大使用經過加工和滅菌的同種異體骨移植材料，這些材料具有更高的安全性、生物相容性和結構支撐力。組織保存、再生醫學和生物增強型移植材料的進步正在改善臨床療效和患者復原。對整形外科研究、創傷治療和微創手術技術的投入增加，為市場擴張創造了機會。發展中地區醫療基礎設施的改善也促進了手術數量的成長。

隨著再生醫學和整形外科的不斷創新，前景仍然光明。 3D列印、組織工程和生物活性移植技術將改善治療效果並擴展臨床應用。對關節重建、脊椎融合手術和創傷重組日益成長的需求將推動市場長期成長。醫療保健領域的持續研究和投資將支持先進骨同種異體移植解決方案的發展。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含幾個關鍵組成部分，旨在幫助您全面了解市場環境：

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的主要促進因素、阻礙因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分根據產品類型、應用、最終用戶和地區將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。這有助於深入了解競爭趨勢和主要參與者所採取的策略。

市場預測：本部分提供基於數據的市場規模和成長模式預測，預測期為指定時期。它綜合考慮了歷史趨勢、當前市場狀況和定量分析，以識別預期的未來趨勢。

區域分析：這包括對主要地理區域的市場表現進行全面檢驗，確定高成長領域和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新興投資機會。本部分重點在於潛在成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，以滿足您的特定需求。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，從而更有效地支援您的策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章：全球同種異體移植市場：依產品分類

  • 市場分析、洞察與預測
  • 結構性同種異體移植
  • 去礦物質骨基質（DBM）
  • 細胞骨基質（CBM）
  • 機械化同種異體移植
  • 其他

第5章：全球同種異體移植市場：依應用領域分類

  • 市場分析、洞察與預測
  • 脊椎固定
  • 創傷與長骨
  • 關節重組
  • 顱顎顏面
  • 牙科
  • 腳和腳踝
  • 運動醫學

第6章：全球同種異體移植市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 醫院
  • 門診手術中心（ASC）
  • 專科診所/牙醫診所

第7章：全球同種異體移植市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Zimmer Biomet
    • Medtronic
    • Stryker
    • Smith+Nephew
    • Lynch Biologics
    • Biomatlante
    • Johnson & Johnson
    • Royal Biologics
    • Baxter International
    • Xtant Medical
    • NovaBone Products
    • Exactech
    • LifeNet Health
    • BioHorizons
    • Globus Medical
    • RTI Surgical
    • Geistlich Pharma
    • MegaGen
    • Novadip
    • Mesoblast
    • Alphatec Spine
    • Institut Straumann
    • NuVasive
簡介目錄
Product Code: VMR112119251

The global bone allografts market size is expected to reach USD 4.07 Billion in 2034 from USD 2.52 Billion in 2025, growing at a CAGR of 5.48 during 2026-2034.This market is experiencing steady growth as orthopedic procedures, spinal surgeries, and reconstructive treatments continue increasing worldwide. Bone allografts provide effective solutions for repairing skeletal defects, supporting bone regeneration, and improving surgical outcomes without requiring additional bone harvesting from patients. Rising prevalence of musculoskeletal disorders, increasing sports injuries, and expanding aging populations are encouraging greater adoption of bone grafting procedures across healthcare systems.

Healthcare providers are increasingly utilizing processed and sterilized allograft materials that offer improved safety, biocompatibility, and structural support. Advances in tissue preservation, regenerative medicine, and biologically enhanced graft materials are improving clinical performance and patient recovery. Growing investments in orthopedic research, trauma care, and minimally invasive surgical techniques are creating favorable opportunities for market expansion. Improved healthcare infrastructure in developing regions is also supporting increased procedure volumes.

The future outlook remains promising as regenerative medicine and orthopedic innovation continue advancing. Three-dimensional printing, tissue engineering, and bioactive graft technologies will improve treatment outcomes and expand clinical applications. Rising demand for joint replacement procedures, spinal fusion surgeries, and trauma reconstruction will strengthen long-term market growth. Continuous research and healthcare investments will support the evolution of advanced bone allograft solutions.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product

  • Structural Allografts
  • Demineralized Bone Matrix (DBM)
  • Cellular Bone Matrices (CBM)
  • Machined Allografts
  • Others

By Application

  • Spinal Fusion
  • Trauma & Long Bone
  • Joint Reconstruction
  • Craniomaxillofacial
  • Dental
  • Foot & Ankle
  • Sports Medicine

By End User

  • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Specialty Clinics/Dental Clinics

COMPANIES PROFILED

  • Zimmer Biomet, Medtronic, Stryker, Smith+Nephew, Lynch Biologics, Biomatlante, Johnson & Johnson, Royal Biologics, Baxter International, Xtant Medical, NovaBone Products, Exactech, LifeNet Health, BioHorizons, Globus Medical, RTI Surgical, Geistlich Pharma, MegaGen, Novadip, Mesoblast, Alphatec Spine, Institut Straumann, NuVasive

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BONE ALLOGRAFTS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product
  • 4.2. Structural Allografts Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Demineralized Bone Matrix (DBM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Cellular Bone Matrices (CBM) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Machined Allografts Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BONE ALLOGRAFTS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Application
  • 5.2. Spinal Fusion Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Trauma & Long Bone Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Joint Reconstruction Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Craniomaxillofacial Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Dental Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.7. Foot & Ankle Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.8. Sports Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BONE ALLOGRAFTS MARKET: BY END USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End User
  • 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Ambulatory Surgical Centers (ASCs) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Specialty Clinics/Dental Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BONE ALLOGRAFTS MARKET: BY REGION 2022-2034 (USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Product
    • 7.2.2 By Application
    • 7.2.3 By End User
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Product
    • 7.3.2 By Application
    • 7.3.3 By End User
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Product
    • 7.4.2 By Application
    • 7.4.3 By End User
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Product
    • 7.5.2 By Application
    • 7.5.3 By End User
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Product
    • 7.6.2 By Application
    • 7.6.3 By End User
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BONE ALLOGRAFTS INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 Zimmer Biomet
    • 9.2.2 Medtronic
    • 9.2.3 Stryker
    • 9.2.4 Smith+Nephew
    • 9.2.5 Lynch Biologics
    • 9.2.6 Biomatlante
    • 9.2.7 Johnson & Johnson
    • 9.2.8 Royal Biologics
    • 9.2.9 Baxter International
    • 9.2.10 Xtant Medical
    • 9.2.11 NovaBone Products
    • 9.2.12 Exactech
    • 9.2.13 LifeNet Health
    • 9.2.14 BioHorizons
    • 9.2.15 Globus Medical
    • 9.2.16 RTI Surgical
    • 9.2.17 Geistlich Pharma
    • 9.2.18 MegaGen
    • 9.2.19 Novadip
    • 9.2.20 Mesoblast
    • 9.2.21 Alphatec Spine
    • 9.2.22 Institut Straumann
    • 9.2.23 NuVasive